The studies done in women focused on oral contraceptive users (6-9), but also included normal control women. Other than these types of investigations, the few studies that have been done in healthy women (not pregnant or using oral contraceptives)
were depletion-repletion studies, which used a return to predepletion values to determine when vitamin B-6 status had normalized (10) (11) (12) 
SUBJECTS AND METHODS

Subjects
The subjects, 10 in study 1 and six in study 2, were healthy women, between the ages of 2 1 and 39 y, who were nonsmokers and not using oral contraceptives. 
RESULTS
Characteristics of the subjects, including weight at the beginning and end of each study, are given in Table  2 . Mean urinary excretion of creatimine and urea nitrogen, hematocrit and hemoglobin concentration did not differ among experimental periods in either study and are not reported here. The PNG content of the diet in study 2 was 0. 145 mg or 6-17% of the total vitamin B-6 intake. The PNG content of the diet in study 1 was not measured, but the only difference from the diet in study 2 was the cereal eaten at breakfast (Table  1) . In study 2, one subject had a 4-PA excretion of < 3.0 moL/d with a vitamin B-6 intake of 1. 14 mg/d (Table 4) . Mean urinary 4-PA excretion represented 60%, 52%, 54%, and 69% of total vitamin B-6 intake in the four respective periods of study 1 and 58%, 50%, and 57% of intake, respectively, in the three periods of study 2.
Mean total urinary vitamin B-6 over the last 3 d of each period was significantly higher in each successive period in study 1 (P < 0.05). In study 2, the mean at the end of the second and third periods were significantly higher (P < 0.05) than that at the end of the previous period (Table  3 ). The suggested value for adequate status is > 0.5 j.tmol/d (I 3, 34), and the means exceeded this value at the end of all four periods of study 1 and at the end of the final two periods in study 2. In both study 1 and study 2, however, two subjects still had values when the vitamin B-6 intake was 1.14 mg/d (Table 4) . In study 2, the mean plasma total vitamin B-6 concentration at the end of period 3 was significantly different from the means at the end of periods 1 and 2 ( 
